Hématologie Lymphome non Hodgkinien
LYM1001 (67856633LYM1001)
A Phase 1, First-in-Human, Open-Label Study of the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-67856633, an Inhibitor of MALT1, in Participants With NHL and CLL
Paris
FREDERIQUE KUHNOWSKI